He proposed that some providers were reluctant to prescribe insulin to patients with type 2 diabetes because of both theoretical concerns (hypoglycaemia, weight gain and the belief that insulin has negative metabolic effects) and practical concerns (patient anxiety about insulin, patient cognitive abilities and the complexity of training patients to administer insulin). The gene discussed is INS; the disease is Anxiety.